Dr Ian Campbell, CEO
Ian is an experienced entrepreneur in life sciences and the diagnostics sector. Previously he served as Chief Executive of Molecular Vision, an Imperial College spin-out company, developing a disposable, quantitative Point–of-Care diagnostic platform, which was acquired by Abingdon Health in 2012. Most recently Ian has served as Commercial Director with Bespak Europe Ltd. Ian has a strong scientific background, gaining his PhD at the University of Glasgow.
Dr Nick Miller-Jones, Technical Director
Nick led the Life Sciences Division of Scientific Generics Ltd, one of the UK’s leading technology consultancy companies and has over 20 years experience in the biotech, life sciences and healthcare industries. He has worked in a number of disciplines including lab-based point-of-care assay development, market analysis and positioning, market entry strategy, identification of companies for acquisition and due diligence on life science companies on behalf of investors.
Tristan Sillars, Finance and Operations Director
A Chartered Accountant, Tristan has concentrated on interim and part-time Head of Finance roles for the last five years as well as raising money for SMEs, aided by his corporate finance and financial modelling expertise. Previously, Tristan worked for KPMG Transaction Services, covering a wide range of deal activity across the UK.
Sarah Couch, Head of Development, Regulatory and Quality Affairs
Sarah has a technical background in assay development and over 16 years of practical experience of Research and Development, Quality and Regulatory affairs within the IVD industry at Dako and ThermosFisher Scientific. She has extensive experience of the IVD product cycle from project initiation through to launch and beyond. Since 2011 she has worked as an independent consultant, providing a wide range of assistance to IVD start-ups, focusing mainly on regulatory compliance and quality management.